US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

288.99

-6.7700-2.29%

Volume:186.23K

Turnover:53.20M

Market Cap:556.16M

PE:- -

High:291.89

Open:288.00

Low:281.72

Close:295.76

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.93

T/O Rate:9.68%

Dividend:1.01

Dividend Rate:0.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

Analysts Offer Insights on Healthcare Companies: Enovis (ENOV) and Aveanna Healthcare Holdings (AVAH)

Labcorp's Alzheimer's Disease Blood Test Cleared by FDA

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)

Regenxbio reports FDA placed clinical hold on RGX-121

Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease

United Parcel Service Invests Over $2 Billion in International, Healthcare, and Supply Chain Solutions Businesses

MT Newswires Live

BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application

Jill Wu Maintains Buy on Long-Term 707 Growth, Slightly Lowering Target Price to HK$34.78 Amid Near-Term Headwinds

Why Fisher & Paykel Healthcare (NZSE:FPH) Is Back In The Spotlight

Simply Wall St.

First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Sanofi (OtherSNYNF)

Aurobindo Pharma's U.S. Unit Receives Four FDA Observations

MT Newswires Live

UG Healthcare to report turnaround for 2HFY2026 and FY2026 following year earlier losses

Aurobindo Pharma’s Lannett Unit Completes Routine U.S. FDA Inspection With Procedural Observations

Xenitra Raises A$1.5m to Drive High-Margin Healthcare and Digital Commerce Growth

Regis Healthcare Sets 2026 AGM Date and Director Nomination Deadline

Regis Healthcare Files Updated ASX Corporate Governance Statement

Regis Healthcare Delivers Strong FY26 Results and Expands Aged Care Portfolio

Regis Healthcare appoints new CFO to drive next growth phase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LABU/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":288.99,"timestamp":1788195314994,"preClose":295.76,"halted":0,"volume":186233,"delay":0,"changeRate":-0.02289018122802266,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Trading","change":-6.77,"latestTime":"08-31 12:55:29 EDT","open":288,"high":291.89,"low":281.7229,"amount":53202317.1313,"amplitude":0.034376,"askPrice":289.36,"askSize":50,"bidPrice":288.81,"bidSize":50,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":295.76,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.00348,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":288.18,"preClose":295.76,"latestTime":"09:29 EDT","volume":1523,"amount":449603.04808999994,"timestamp":1788182999999,"change":-7.58,"changeRate":-0.025629,"amplitude":0.050003},"postHourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"volumeRatio":0.929379,"impliedVol":0.9319,"impliedVolPercentile":0.5817},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.929379,"shares":1924486,"dividePrice":1.0056,"high":291.89,"amplitude":0.034376,"preClose":295.76,"low":281.7229,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":288.99,"eps":0,"divideRate":0.00348,"volume":186233,"delay":0,"ttmEps":0,"open":288,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":308.33,"twentyDayClose":228.04,"sixtyDayClose":179.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661279504","title":"Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279504","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":"– Supplemental Biologics License Application (BLA) expected to be filed with the Food and Drug Administration (FDA) in November 2026 – – Supplemental BLA will be supported by results from three Phase ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349666/0/en/humacyte-confirms-plans-for-atev-supplemental-bla-filing-for-dialysis-access-following-fda-discussions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585","AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275904","title":"Analysts Offer Insights on Healthcare Companies: Enovis (ENOV) and Aveanna Healthcare Holdings (AVAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275904?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:40","pubTimestamp":1787571627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Enovis (ENOV) and Aveanna Healthcare Holdings (AVA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enovis-enov-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enovis-enov-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","IE00B19Z6F94.USD","IE0034390439.USD","BK4588","ENOV","BK4196","AVAH","BK4585","XLV","LABU","LU2065732104.USD","BK4082","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275622","title":"Labcorp's Alzheimer's Disease Blood Test Cleared by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275622","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275622?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:39","pubTimestamp":1787571550,"startTime":"0","endTime":"0","summary":"Labcorp  said Monday that its blood test that detects Alzheimer's disease is now available after receiving clearance from the US Food and Drug Administration.The company said its Elecsys pTau-217 test, developed by Roche Diagnostics, helps identify amyloid pathology associated with Alzheimer's disease in people aged 55 and older with signs, symptoms, or complaints of cognitive decline.The test, according to Labcorp, is the only FDA-cleared single-biomarker blood test to rule in and rule out amyloid pathology in specialty and primary care settings.Labcorp said it expects the test to be available nationwide in the coming months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","LU2237438978.USD","LU1059921491.USD","LU0742534661.SGD","LU0048573561.USD","BK4550","LABU","BK4585","LU0251131958.USD","BK4588","LH","LU0006061336.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275889","title":"Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275889?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Hea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","LU0029874061.USD","BK4007","BK4585","BK4196","LU0128526141.USD","AGL","BK4581","BK4588","BK4539","HCSG","XLV","XBI","LABU","BK4137","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627309","title":"Regenxbio reports FDA placed clinical hold on RGX-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627309","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570406,"startTime":"0","endTime":"0","summary":"Regenxbio (RGNX) provided an update on its investigational gene therapy, RGX-121, for the treatment of Mucopolysaccharidosis type II, also known as...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","CNCR","RGNX","LABU","LFSC","BK4563","BK4588","TBXU","BK4585","GNOM","BK4139","FBT","IBBQ","BK4505","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275850","title":"Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275850","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275850?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:16","pubTimestamp":1787570164,"startTime":"0","endTime":"0","summary":"Labcorp (LH) announced it will offer the Elecsys pTau-217 test following clearance by the U.S. FDA. Developed by Roche Diagnostics (RHHBY), the blo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/labcorp-to-offer-elecsys-ptau-217-test-for-alzheimers-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/labcorp-to-offer-elecsys-ptau-217-test-for-alzheimers-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HRTS","LABU","LH","BK4007","LU0006061336.USD","BK4588","RHHBY","LU0742534661.SGD","CANC","LU1059921491.USD","LU0251131958.USD","BK4585","LU0048573561.USD","LU0251142724.SGD","03165","LU2237438978.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273466","title":"United Parcel Service Invests Over $2 Billion in International, Healthcare, and Supply Chain Solutions Businesses","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273466","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273466?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:10","pubTimestamp":1787569843,"startTime":"0","endTime":"0","summary":"United Parcel Service Invests Over $2 Billion in International, Healthcare, and Supply Chain Solutions Businesses","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B7SZLL34.SGD","SHPP","LU0496365809.HKD","LU1430594728.SGD","IE00BJJMRY28.SGD","LU2133065610.SGD","IYT","IE00B19Z3B42.SGD","LABU","XLV","LU0128525689.USD","LU0211326839.USD","LU0061475181.USD","BK4131","LU0320765646.SGD","LU0029874061.USD","UPS","LU1267930227.SGD","IE0002270589.USD","HCSG","LU0052756011.USD","LU1162221912.USD","LU0128526141.USD","LU0211331839.USD","LU0070302665.USD","IE00BJJMRX11.SGD","LU0320765489.SGD","LU1894683264.USD","BK4581","UBCP","LU1894683348.USD","UPSG","BK4534","HULL","IE00B19Z3581.USD","DOCK","LU1074936037.SGD","LU0211326755.USD","LU0208291251.USD","SUPL","IE00BFSS8Q28.SGD","LU0149725797.USD","BK4585","XBI","IE00B7KXQ091.USD","IE0004445015.USD","BK4137","LU2237438978.USD","LU0310800965.SGD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181313648","title":"BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1181313648","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181313648?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566138,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on August 21, 2026, its independently developed KJ015 injection, a subcutaneous formulation of a bispecific antibody targeting HER2, received Investigational...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BMED","LABU","BK4585","PSYK","MDTX","BK4588","02659","IBBQ","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273062","title":"Jill Wu Maintains Buy on Long-Term 707 Growth, Slightly Lowering Target Price to HK$34.78 Amid Near-Term Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273062?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:35","pubTimestamp":1787564142,"startTime":"0","endTime":"0","summary":"3SBio, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jill Wu from CMB International Securities maintained a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/jill-wu-maintains-buy-on-long-term-707-growth-slightly-lowering-target-price-to-hk34-78-amid-near-term-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/jill-wu-maintains-buy-on-long-term-707-growth-slightly-lowering-target-price-to-hk34-78-amid-near-term-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","XBI","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661274331","title":"Why Fisher & Paykel Healthcare (NZSE:FPH) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2661274331","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661274331?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:27","pubTimestamp":1787563638,"startTime":"0","endTime":"0","summary":"Why Fisher & Paykel Healthcare guidance matters now\nFisher & Paykel Healthcare (NZSE:FPH) drew investor attention on 20 August 2026 after updating its outlook for the 2027 financial year, with higher full year earnings guidance and fresh expectations for the first half.\nSee our latest analysis for Fisher & Paykel Healthcare.\nThe guidance upgrade on 20 August 2026 comes after a strong run in Fisher & Paykel Healthcare shares, with a 12.18% 1 month share price return, a 20.39% 3 month share...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/875015-main-header/1585186825715","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/875015-main-header/1585186825715"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-fph/fisher-paykel-healthcare-shares/news/why-fisher-paykel-healthcare-nzsefph-is-back-in-the-spotligh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-fph/fisher-paykel-healthcare-shares/news/why-fisher-paykel-healthcare-nzsefph-is-back-in-the-spotligh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4193","BK4581","FPH.NZ","XLV","FPH","BK8004","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661022177","title":"First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2661022177","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661022177?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:00","pubTimestamp":1787558400,"startTime":"0","endTime":"0","summary":"The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough The","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349489/0/en/first-patient-treated-in-pioneer-1-registrational-trial-of-privosegtor-for-optic-neuritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","LU0795875086.SGD","IE00B775SV38.USD","LU1978683503.SGD","LU2028103732.USD","LU0724618433.USD","LU0098860793.USD","LU1074936037.SGD","LU1854103824.USD","LU2298322129.HKD","BK4581","BK4081","LU2347655156.SGD","LU1244550221.USD","KBWB","LU0882574139.USD","LU0267386448.USD","BK4127","LU0528227936.USD","LU1732800096.USD","IE00B3S45H60.SGD","IAI","LU1244550494.USD","BK4141","LU1791710582.SGD","LU1732799900.SGD","BK4504","BK4588","EMA","LU0912757837.SGD","IE00BD6J9T35.USD","IE00BZ199S13.USD","LU0225283273.USD","LU2089284900.SGD","LU0348723411.USD","LU1720051017.SGD","LU1861220033.SGD","LU0158827948.USD","LU1668664300.SGD","LU0390134368.USD","IE00BZ1G4Q59.USD","ONG","LU0106261372.USD","LU2089283258.USD","ON","LU0234570918.USD","LABU","ONX","LU1983260115.SGD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226346","title":"Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Sanofi (OtherSNYNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226346","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226346?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rani Therapeutics Holdings (RANI) and Sanofi (SNYNF)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","SNYNF","LU0029874061.USD","LABU","BK4007","RANI","BK4588","XLV","XBI","BK4539","HCSG","BK4581","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222807","title":"Aurobindo Pharma's U.S. Unit Receives Four FDA Observations","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222807","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222807?lang=en_us&edition=fundamental","pubTime":"2026-08-24 13:30","pubTimestamp":1787549449,"startTime":"0","endTime":"0","summary":"Aurobindo Pharma  said a routine inspection of its wholly owned step-down subsidiary, Lannett Co. in Seymour, Indiana, by U.S. Food and Drug Administration, concluded with four observations.The inspection was conducted from Aug. 17 to 21, according to a Monday filing on NSE. The company said the observations were procedural in nature and it will respond to the U.S. FDA within the specified timeline.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662024122","title":"UG Healthcare to report turnaround for 2HFY2026 and FY2026 following year earlier losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2662024122","media":"Teo Zheng Long","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662024122?lang=en_us&edition=fundamental","pubTime":"2026-08-24 12:51","pubTimestamp":1787547117,"startTime":"0","endTime":"0","summary":"UG Healthcare expects to report its unaudited financial results after the close of trading on Aug 26.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/capital/results/ug-healthcare-report-turnaround-2hfy2026-and-fy2026-following-year-earlier-losses?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/capital/results/ug-healthcare-report-turnaround-2hfy2026-and-fy2026-following-year-earlier-losses?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["LU0029874061.USD","BK4137","HCSG","XLV","LU0128526141.USD","LABU","UG","XBI","BK4588","BK4585","BK4183","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661024090","title":"Aurobindo Pharma’s Lannett Unit Completes Routine U.S. FDA Inspection With Procedural Observations","url":"https://stock-news.laohu8.com/highlight/detail?id=2661024090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661024090?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:52","pubTimestamp":1787543579,"startTime":"0","endTime":"0","summary":"Aurobindo Pharma Ltd ( ($IN:AUROPHARMA) ) has shared an announcement. Aurobindo Pharma has reported the completion of a routine U.S. FDA inspection...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurobindo-pharmas-lannett-unit-completes-routine-u-s-fda-inspection-with-procedural-observations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurobindo-pharmas-lannett-unit-completes-routine-u-s-fda-inspection-with-procedural-observations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCIN","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241286","title":"Xenitra Raises A$1.5m to Drive High-Margin Healthcare and Digital Commerce Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241286?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:36","pubTimestamp":1787531811,"startTime":"0","endTime":"0","summary":"AuMake Ltd. ( ($AU:XEN) ) has issued an announcement. Xenitra Limited has raised A$1.5 million via a placement of 500 million new shares at A$0.003...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xenitra-raises-a1-5m-to-drive-high-margin-healthcare-and-digital-commerce-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xenitra-raises-a1-5m-to-drive-high-margin-healthcare-and-digital-commerce-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","BK4581","LU0128526141.USD","BK4585","LABU","HCSG","BK4588","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661492052","title":"Regis Healthcare Sets 2026 AGM Date and Director Nomination Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2661492052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661492052?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:42","pubTimestamp":1787528539,"startTime":"0","endTime":"0","summary":"An announcement from Regis Healthcare Ltd. ( ($AU:REG) ) is now available. Regis Healthcare has scheduled its 2026 Annual General Meeting for Tuesd...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-sets-2026-agm-date-and-director-nomination-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-sets-2026-agm-date-and-director-nomination-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","XLV","XBI","LU0029874061.USD","LABU","BK4229","RGS","AGM","BK4588","BK4195","BK4585","LU0128526141.USD","BK4137","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661766249","title":"Regis Healthcare Files Updated ASX Corporate Governance Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661766249","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661766249?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:40","pubTimestamp":1787528447,"startTime":"0","endTime":"0","summary":"Regis Healthcare Ltd. ( ($AU:REG) ) has provided an announcement. Regis Healthcare Limited has lodged its corporate governance statement for the ye...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-files-updated-asx-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-files-updated-asx-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEMX","NUDV","CVLC","NUSC","ESG","DSI","BK4585","HAPY","BK4192","ESGY","BK4137","FDRX","JSTC","LABU","CHRI","VOTE","EXEQ","LU0029874061.USD","HCSG","RGS","ESGV","ESML","BK4588","LOPP","XBI","SUSA","CDEI","HAPI","ESGA","XLV","BK4581","SSPX","MDCP","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661924976","title":"Regis Healthcare Delivers Strong FY26 Results and Expands Aged Care Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2661924976","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661924976?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:38","pubTimestamp":1787528331,"startTime":"0","endTime":"0","summary":"Regis Healthcare Ltd. ( ($AU:REG) ) just unveiled an announcement. Regis Healthcare reported a strong FY26, with revenue from services rising 16% t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-delivers-strong-fy26-results-and-expands-aged-care-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-delivers-strong-fy26-results-and-expands-aged-care-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","XLV","BK4192","XBI","BK4581","LU0029874061.USD","RGS","LU0128526141.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661324916","title":"Regis Healthcare appoints new CFO to drive next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2661324916","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661324916?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:05","pubTimestamp":1787526354,"startTime":"0","endTime":"0","summary":"An update from Regis Healthcare Ltd. ( ($AU:REG) ) is now available. Regis Healthcare has appointed experienced finance executive Stuart Hooper as ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-appoints-new-cfo-to-drive-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-appoints-new-cfo-to-drive-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4137","LU0128526141.USD","HCSG","XLV","LABU","LU0029874061.USD","BK4581","RGS","XBI","BK4585","BK4192"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":12,"totalSize":398,"code":"91000000","status":"200"}]}}